PRI whereabouts – Spring 20180

PRI whereabouts – Spring 2018

Richard Ellis, Business Development Manager

Following our successful travels in late 2017 and early 2018 Magali Cordaillat-Simmons and myself will be out and about again throughout the spring attending a variety of conferences related to the world of Microbiotic Medicinal Products.

Please feel free to get in touch with us to set up a meeting at any of the following events if you are interested in taking your products to market here in Europe.

  1. Next week we’ll be in Paris 14-15 March at Pharmabiotics 2018 which was created by the PRI over 3 years ago. We’re expecting in excess of 180 attendees this year and have a number of really interesting sessions on regulatory affairs globally; skin; Bioinformatics; Taxonomy; Innovation showcase; Biomarkers and so on!
  2. Immediately following that we fly off to Rotterdam to the Microbiome R&D & Business Collaboration Forum 21-22nd March! Probably the biggest conference around the Human Microbiome internationally, my colleague Magali Cordaillat-Simmons will be overseeing a round table on “the regulatory aspects around LBPs”
  3. The month of May at least one of us will be at Microbiome Invest in London to keep abreast of any new start-ups that might be interested in joining the PRI!
  4. June will see us in the US, in Boston to be precise, at the excellent Microbiome Drug Development Summit 19-22nd where we’ll be looking to continue to forge partnerships with US-based organisations looking to take their products to market in Europe.

The PRI is a non-profit European association with 4 major objectives to get Microbiotic Medicinal Products and therapies recognised as medicines and as such provide regulatory guidelines to our members when taking their products to market in Europe:

  1. to get Microbiotic Medicinal Products and therapies recognised as medicines and as such provide regulatory guidelines to our members when taking their products to market in Europe
  2. to offer our members value by operating Europe’s only network in the Human Microbiome supply chain!
  3. to stimulate and exchange scientific discussion between our members. We will be holding scientific task groups next year in Paris with our members around the bioinformatics challenge and the microbiome.
  4. To create a link between academia and industry enabling industrials to learn about new science and academics to meet with potential investors.

Here are some videos of our members and staff talking about the PRI.

We currently have members who are at stage III clinical trials with Microbiotic Medicinal Products in Europe.

International Pharmabiotics Conference 29-30 October 2014 – Paris, France, Hotel Meridien Etoile0

Join us for this new and ground-breaking conference

The International Pharmabiotics Conference is a new event organised by Quartz Business Media in association with the Pharmabiotic Research Institute and will be held 29-30 October at the Meridien Etoile Hotel, Paris.

The conference addresses “Treating diseases with probiotics” and is aimed at pharmaceutical, medical and regulatory professionals who are interested in finding new ways to overcome several common diseases through medicinal probiotics as drug products.

The conference will focus on the following main themes:

  • Regulatory hurdles
  • Gastroenterology – new therapeutic approaches and today’s practice
  • Obesity and metabolic syndrome
  • Urogenital pathologies

We would like to invite experts in this field to speak or present an informative poster at the conference. For details on the call for abstract process please click here.

This important inaugural conference will held to build on a growing community of leaders in the field of pharmabiotics, microbiota and human health; and offer attendees a superb insight into the huge opportunities that exist for the future of medicine and pharmaceutical organisations. Don’t miss out – to find out more subscribe to the newsletter now

PRI Shared Stand – CPHI Worldwide 20120

CPHIMadrid, Spain – October 9 – 11, 2012

CPhI Worldwide was first held in 1990 and so 2012 marks the 23rd editionof
this prestigious and industry leading event. From just 250 delegates at
the inaugural convention, visitor numbers have subsequently grown more
than one hundred fold to over 29,000 attendees from over 140 countries.
The event now covers more than 60,000 sqm of exhibition space, hosting
over 1,900 exhibitors and is the market leader for the global pharmaceutical ingredients industry.

Visit the PRI shared stand, along with members Probionov and Lyocentre Laboratories, in Madrid – Stand 10 B 11.

Other PRI members exhibiting at CPHI 2012:





Merck Médication Familiale